Lykos Therapeutics Slashes Workforce, Reshuffles Leadership After FDA Rejection

August 22, 2024

MDMA for PTSD: Setback Sparks New Battle Plan

August 14, 2024

Mr. Cannabis Law Rebrands as LumaLex Law, Expands Into Psychedelics

July 21, 2024

DEA: MIRA-55 Marijuana Analog Not a Controlled Substance

May 29, 2024

Psilocybin Spurs Dynamic Brain ‘Hyperconnectivity’ Linked to Psychedelic Epiphanies

May 24, 2024

AbbVie, Gilgamesh to Collaborate on Development of Novel Neuroplastogens

May 22, 2024